Literature DB >> 26176393

Oral Propranolol for Infantile Hemangioma.

Arturo Tozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26176393     DOI： 10.1056/NEJMc1503811

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Infantile hemangioma: factors causing recurrence after propranolol treatment.

Authors:  Lei Chang; Dongze Lv; Zhang Yu; Gang Ma; Hanru Ying; Yajing Qiu; Yifei Gu; Yunbo Jin; Hui Chen; Xiaoxi Lin
Journal:  Pediatr Res       Date:  2017-10-11       Impact factor: 3.756

2.  Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.

Authors:  Virginia Albiñana; Karina Villar Gómez de Las Heras; Gemma Serrano-Heras; Tomás Segura; Ana Belén Perona-Moratalla; Mercedes Mota-Pérez; José María de Campos; Luisa María Botella
Journal:  Orphanet J Rare Dis       Date:  2015-09-22       Impact factor: 4.123

3.  When to stop propranolol for infantile hemangioma.

Authors:  Lei Chang; Yifei Gu; Zhang Yu; Hanru Ying; Yajing Qiu; Gang Ma; Hui Chen; Yunbo Jin; Xiaoxi Lin
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.